Loading
Life sciences · Interventional Study
ClinicalTrials.gov · October 5, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Interventional Study.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT05570721). This is a study registration, not published results. Lead sponsor: University of North Carolina, Chapel Hill. Recruitment status: COMPLETED. Phase: NA. Study type: INTERVENTIONAL. Enrollment: 41 participants (ACTUAL). Conditions: Menopause, Depression, Heart Disease in Women, Stress. Interventions: BEHAVIORAL: Trier Social Stress Test. Primary outcome measures: Salivary aldosterone (pg/mL) levels at rest (before the stress task). , Immediately prior to the stress task.; Change in salivary aldosterone (pg/mL) levels in response to the stress task. , Immediately prior to the stress task and at intervals of 0, 10, and 20 minutes after the stress task.; Plasma aldosterone (pg/mL) levels at rest (before the stress task). , Immediately prior to the stress task.; Change in plasma aldosterone (pg/mL) levels in response to the stress task. , Immediately prior to and at 0 minutes after the stress task.; Plasma angiotensin II (pg/mL) levels at rest (before the stress task). , Immediately prior to the stress task.; Change in plasma angiotensin II (pg/mL) levels in response to the stress task. , Immediately prior to and at 0 minutes after the stress task.; Plasma renin (pg/mL/hr) levels at rest (before the stress task). , Immediately prior to the stress task.; Change in plasma renin (pg/mL/hr) levels in response to the stress task , Immediately prior to and at 0 minutes after the stress task. Brief summary: Depression is a known risk factor for cardiovascular disease (CVD), and this comorbidity contributes significantly to the morbidity and mortality of women. The menopausal transition or perimenopause is a period of vulnerability for both depression and CVD, making it a key time to study this critical public health issue. This research will preliminarily explore whether disruption in two novel stress pathways 1) the renin-angiotensin-aldosterone system (RAAS) and autonomic nervous system (ANS) and their relationship may underlie the link between these illnesses. Findings will provide important insight into potential mechanisms by which depression during perimenopause may increase risk for CVD in midlife women, which will inform potential risk reduction and treatment strategies that can improve health outcomes in this population.